About Novacyt Group and Primerdesign™
Novacyt is a rapidly growing, international diagnostics group specialising in clinical solutions used in oncology, microbiology, haematology and serology testing. The Group has a strong intellectual property portfolio and process ‘know-how’ in the key technologies used across its business units.
Primerdesign™, part of the Novacyt Group, is a leading and innovative expert in real-time PCR and DNA chemistry. Primerdesign™ was the first European company to respond to the threat of the global COVID-19 pandemic by developing a molecular test for the virus. Primerdesign’s gold standard COVID-19 Test Kits are accredited with CE-IVD certification and FDA Emergency Use Authorisation from major regulatory authorities, including the US FDA and the WHO.
Primerdesign™ has collaborated with AstraZeneca, GSK and University of Cambridge to support the UK COVID-19 testing effort. We can fully meet the growing demand of the SARS-CoV-2 testing requirement with our state of art production process.